To evaluate the regulatory effect of IPA on CD4+ T cell functionality in IBD patients, peripheral blood samples were obtained from 53 patients with active IBD and 20 healthy subjects (detailed participant information shown in Supplementary table S1). This evidence concerns the gene CD4 and inflammatory bowel disease.